UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000047634
Receipt number R000054315
Scientific Title Monitoring of microvascular and hemodynamic changes in the skin lesion with scleroderma
Date of disclosure of the study information 2022/05/09
Last modified on 2023/05/02 21:05:34

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Monitoring of microvascular and hemodynamic changes in the skin lesion with scleroderma

Acronym

Monitoring of microvascular and hemodynamic changes in the skin lesion with scleroderma

Scientific Title

Monitoring of microvascular and hemodynamic changes in the skin lesion with scleroderma

Scientific Title:Acronym

Monitoring of microvascular and hemodynamic changes in the skin lesion with scleroderma

Region

Japan


Condition

Condition

Systemic sclerosis

Classification by specialty

Clinical immunology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Correlation between a quantitative evaluation method by raster scanning photoacoustic mesoscope (RSOM) and conventional evaluation methods such as skin scores, vascular findings in nail folds, organ complications, and immune abnormalities in patients with scleroderma.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Correlation between raster scanning optoacoustic mesoscopy (RSOM) findings and skin scores in patients with scleroderma.

Key secondary outcomes

Correlation between raster scanning optoacoustic mesoscopy (RSOM) findings and organ complications in patients with scleroderma.
Differences in raster scanning optoacoustic mesoscopy (RSOM) findings among healthy controls and patients with scleroderma and other connective tissue disorders.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Raster scanning photoacoustic mesoscope (RSOM)

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with scleroderma and other connective tissue disorders

Key exclusion criteria

None

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Shunichi
Middle name
Last name Fujita

Organization

Kawasaki Medical School

Division name

Department of Rheumatology

Zip code

701-0192

Address

577 Matsushima, Kurashiki-City, Okayama

TEL

0864621111

Email

shunichi@med.kawasaki-m.ac.jp


Public contact

Name of contact person

1st name Shunichi
Middle name
Last name Fujita

Organization

Kawasaki Medical School

Division name

Department of Rheumatology

Zip code

701-0192

Address

577 Matsushima, Kurashiki-City, Okayama

TEL

0864621111

Homepage URL


Email

shunichi@med.kawasaki-m.ac.jp


Sponsor or person

Institute

Kawasaki Medical School

Institute

Department

Personal name



Funding Source

Organization

Kawasaki Medical School

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kawasaki Medical School Ethics Review Board

Address

577 Matsushima, Kurashiki-City, Okayama

Tel

0864621111

Email

kmsrec@med.kawasaki-m.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 05 Month 09 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2022 Year 04 Month 18 Day

Date of IRB

2022 Year 07 Month 22 Day

Anticipated trial start date

2022 Year 05 Month 09 Day

Last follow-up date

2026 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 05 Month 01 Day

Last modified on

2023 Year 05 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000054315


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name